- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Foster City Today
By the People, for the People
Terns Pharmaceuticals Grants Inducement Shares to New Employees
The clinical-stage oncology company awarded restricted stock units to three new hires.
Apr. 3, 2026 at 5:28am
Got story updates? Submit your updates here. ›
Terns Pharmaceuticals' new employee inducement grants align the interests of its growing team with those of its shareholders.Foster City TodayTerns Pharmaceuticals, a clinical-stage oncology company, announced that it has granted equity inducement awards to three new employees under the terms of the company's 2022 Employment Inducement Award Plan. The company awarded a total of 23,316 restricted stock units (RSUs) of Terns common stock, which will vest over four years as the employees continue their service.
Why it matters
Inducement grants like these are common practice for public companies to attract and retain top talent, especially in the competitive biotech and pharmaceutical industries. The awards align the new employees' interests with those of Terns' shareholders as the company continues to advance its clinical-stage oncology pipeline.
The details
The equity awards were approved by Terns' Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4), which allows companies to make such inducement grants to new employees as a material incentive for them to join the company.
- The grants were made as of April 1, 2026.
The players
Terns Pharmaceuticals, Inc.
A clinical-stage oncology company focused on delivering high-impact medicines.
Compensation Committee
The committee of Terns' Board of Directors that approved the inducement grants.
The takeaway
Terns' inducement grants to new hires demonstrate the company's commitment to building a talented team as it advances its oncology pipeline. These types of awards are common practice for public biotech firms looking to attract top scientific and clinical talent in a competitive industry.
